Mapping large numbers of results may take a few moments.
Search Results
Showing 51 - 100 of 340 results found.
Company | Activity | Company Description | Location | |
---|---|---|---|---|
Company Bedrock Therapeutics Inc. | Activity: Research and Development | Company Description Bedrock Therapeutics is an AAV research and development company developing platform technologies and therapeutics. | Location Raleigh | |
Company Belhaven Biopharma Inc. | Activity: Research and Development | Company Description Belhaven Biopharma is developing dry powder nasal products for a variety of indications. | Location Raleigh | |
Company BENANOVA Inc. | Activity: Research and Development | Company Description BENANOVA develops antimicrobial nanotechnology products for the disinfectant, cosmetic and agricultural industries. | Location Raleigh | |
Company Bio 54 LLC | Activity: Research and Development | Company Description Bio 54 is developing a hand-held drug delivery device for patients to treat external bleeding from minor wounds in anticoagulant patients. | Location Chapel Hill | |
Company BioAesthetics Corporation | Activity: Research and Development | Company Description BioAesthetics Corporation is developing biomaterials, including the NACgraft, a nipple areolar complex graft to be used in regenerating the nipple-areolar complex for mastectomy patients. | Location Durham | |
Company Biofidelity Inc. | Activity: Research and Development | Company Description Biofidelity provides simple, high-sensitivity diagnostic assays which enable patient monitoring and precision medicine. | Location Morrisville | |
Company BioGreen Synergy Inc. | Activity: Research and Development | Company Description BioGreen Synergy manufactures, grows and provides algae-based products for use in pharmaceuticals, nutraceuticals and cosmeceuticals. | Location Greensboro | |
Company BioIVT | Activity: Research and Development | Company Description BioIVT provides biological specimens, specializing in control and disease state human and animal tissues. This site develops and commercializes cell-based drug toxicity-testing products for pharmaceutical development, based on hepatocyte technologies. | Location Durham | |
Company BioKier Inc. | Activity: Research and Development | Company Description BioKier develops proprietary adjuvant treatments for diabetes and related disorders. BioKier has identified a therapeutic opportunity based on gastric bypass surgery and is developing several novel treatments for cardiometabolic diseases including hyperlipidemia and insulin resistance. | Location Chapel Hill | |
Company Biorg Inc. | Activity: Research and Development | Company Description Biorg is developing and commercializing organoid technology for use in life science applications such as diagnostics, drug screenings and toxicology. | Location Winston-Salem | |
Company BioRxn LLC | Activity: Research and Development | Company Description BioRxn develops NMR-based metabolomic technology, including bioreactor and artificial liver systems, for non-invasive monitoring of metabolic biomarkers. BioRxn also provides conventional metabolomic services. | Location Chapel Hill | |
Company Biotech Restorations LLC | Activity: Research and Development | Company Description Biotech Restorations formulates bioremediation products for the cleanup of petroleum and chlorinated hydrocarbons including gasoline and diesel, organochloride pesticides, PCBs and volatile organic chemicals in soil, sediment and groundwater. | Location Denver | |
Company Black Swan Pharmaceuticals Inc. | Activity: Research and Development | Company Description Black Swan Pharmaceuticals is developing preclinical gene targeting therapeutics for motor neurone disease (MND) / Amyotrophic Lateral Sclerosis (ALS) and other neurological disorders. | Location Wake Forest | |
Company Bloodless Dx LLC | Activity: Research and Development | Company Description Bloodless Dx is an assay development company focused on bloodless diagnostics. | Location Apex | |
Company BMPolytech LLC | Activity: Research and Development | Company Description BMPolytech is developing a new class of synthetic materials, tissue-mimetic Brush-like Polymer Networks, for use in advanced biomedical devices, such as implants, drug delivery devices and wound care. | Location Chapel Hill | |
Company Boundless Science LLC | Activity: Research and Development | Company Description Boundless Science develops a device for heart and lung oxygenation as a safer alternative to ECMO. | Location Chapel Hill | |
Company Brighton Development LLC | Activity: Research and Development | Company Description Brighton Development develops sterilizing technologies and antimicrobial medical plastics. | Location Cary | |
Company Brightseed (Durham) | Activity: Research and Development | Company Description Brightseed developed an AI-driven discovery platform, Forager, to identify plant bioactives as potential therapeutic solutions. | Location Durham | |
Company Brinter (Winston-Salem) | Activity: Research and Development | Company Description Brinter develops 3D bioprinted implants that mimic native cartilage. Brinter also sells 3D bioprinting equipment. | Location Winston-Salem | |
Company Bryn Pharma LLC | Activity: Research and Development | Company Description Bryn Pharma is developing a nasal solution for the administration of emergency epinephrine for the treatment of anaphylaxis. | Location Raleigh | |
Company Caeregen Therapeutics LLC | Activity: Research and Development | Company Description Caeregen Therapeutics develops therapies which repair, restore, and protect damaged and diseased tissues by reactivating the pathways and signaling which accompany normal cellular and tissue development. Caeregen is developing Noregen, a recombinant protein mimetic of human norrin-derived growth factor for the potential treatment of retinal-related vision loss. | Location Chapel Hill | |
Company Cancer Advances Inc. | Activity: Research and Development | Company Description Cancer Advances, a subsidiary of Cato Bioventures, develops immunomodulator therapeutics to treat gastrointestinal cancers. | Location Durham | |
Company Cell Spinpod LLC | Activity: Research and Development | Company Description Cell Spinpod develops and sells rotating suspension cell culture devices. Cell spinpods are miniature rotating bioreactors that keep cells, spheroids, or microorganisms in 3D suspension culture. | Location Chapel Hill | |
Company Cellective BioTherapy Inc. | Activity: Research and Development | Company Description Cellective BioTherapy is developing cellular and monoclonal antibody-based platforms for treating cancers, autoimmunity and immunodeficiency through the manipulation of B cells and their functional subsets. | Location Chapel Hill | |
Company Cellex Inc. | Activity: Research and Development | Company Description Cellex develops, manufactures and markets diagnostic tests suitable for point-of-care use. These tests use a platform technology called Homogeneous Biochemiluminescence Assay (HBA), which enables assays that are highly sensitive and easy-to-use. | Location Cary | |
Company CellSolutions LLC | Activity: Research and Development | Company Description CellSolutions develops liquid-based preparation and evaluation systems for cytology applications. The company's primary area of focus is women's health, including cervical cancer screening, precancer detection and evaluation of infectious disease. | Location Greensboro | |
Company Cerulean Scientific | Activity: Research and Development | Company Description Cerulean Scientific has developed an omniphobic coating for implantable medical devices to resist pathogen colonization and thrombosis. Cerulean develops products using the coating for neurosurgical and vascular surgical applications. | Location Durham | |
Company Cervu Health | Activity: Research and Development | Company Description Cervu is developing an intravaginal pelvic floor physical therapy tool to help female cancer survivors manage chronic pelvic pain and dyspareunia (pain with sexual intercourse). | Location Cary | |
Company Chesson Laboratory Associates Inc. | Activity: Research and Development | Company Description Chesson Labs develops prescription and over-the-counter polymer-based medical products for wound care and skin and nail care products. | Location Durham | |
Company Citranvi Biosciences LLC | Activity: Research and Development | Company Description Citranvi develops vaccine technology platforms and products, using comprehensive structure-based vaccine design, broadly applicable to a variety of viral pathogens such as Cytomegalovirus, Epstein-Barr Virus and Coronaviruses. | Location Chapel Hill | |
Company CivaTech Oncology Inc. | Activity: Research and Development | Company Description CivaTech Oncology has developed targeted implantable radiation devices to treat many cancer types. Products provide a targeted, customized radiation dose during a surgical resection procedure or in outpatient therapies to treat cancers. | Location Morrisville | |
Company CLAIRIgene LLC | Activity: Research and Development | Company Description CLAIRIgene develops viral vector platforms for gene therapy products to treat central nervous system diseases and conditions. | Location Durham | |
Company Clarus Biologics Inc. | Activity: Research and Development | Company Description Clarus Biologics is developing innovative vaccine and immunotherapeutic products using a novel and proprietary self-amplifying mRNA delivery and viral particle technology platform. Its first innovation is a vaccine VLP that enhances the effectiveness, efficiency and availability of vaccines. | Location Chapel Hill | |
Company Clue Genetics | Activity: Research and Development | Company Description Clue Genetics analyzes microbial genomes from fungi to identify novel active compounds that may have human health, pest resistance and environmental applications. | Location Hillsborough | |
Company Codetta Bio Inc. | Activity: Research and Development | Company Description Codetta Biosciences is developing a unique digital spatial polymerase chain reaction (dsPCR) and digital spatial immuno polymerase chain reaction (dsiPCR) platform for multi-omic analysis from a single specimen. | Location Durham | |
Company Cognosci Inc. | Activity: Research and Development | Company Description Cognosci develops neurorestorative therapies for Alzheimer's disease, multiple sclerosis, traumatic brain injury, nerve crush and other disease and trauma indications. | Location Durham | |
Company Columbia Life Systems Inc. | Activity: Research and Development | Company Description Columbia Life Systems is developing a computer-controlled oxygen blender for therapeutic research. | Location Raleigh | |
Company Concentrx Pharmaceuticals Inc. | Activity: Research and Development | Company Description Concentrx develops inhaled prescription products for asthma and COPD, including a unit dose disposable dry powder inhaler. | Location Durham | |
Company Contego Medical LLC | Activity: Research and Development | Company Description Contego Medical develops embolic protection devices for cardiovascular and peripheral vascular procedures, designed to simplify catheter-based procedures. | Location Raleigh | |
Company Coprata Inc. | Activity: Research and Development | Company Description Coprata develops non-invasive physiological sampling technologies to detect or manage acute and chronic gastrointestinal diseases, provide early warning of infectious disease and monitor personalized wellness. | Location Durham | |
Company Couragen Biopharmaceutics LLC | Activity: Research and Development | Company Description Couragen Biopharmaceutics develops gene and protein therapy products for preclinical and clinical use for the treatment of genetic and chronic diseases. Couragen also provides custom adeno-associated virus vectors as a tool for laboratory research. | Location Chapel Hill | |
Company Creyon Bio | Activity: Research and Development | Company Description Creyon Bio is a drug development company engineering RNA-based medicines and their components. | Location Research Triangle Park | |
Company CytexOrtho | Activity: Research and Development | Company Description CytexOrtho develops bio-artificial devices to treat osteoarthritis and other musculoskeletal diseases. | Location Durham | |
Company Data Driven Bioscience Inc. | Activity: Research and Development | Company Description Data Driven Bioscience uses genomic tests, datasets and machine learning solutions to enable hospitals and pharmaceutical companies to diagnose cancer and personalize cancer treatment. | Location Durham | |
Company Datar Cancer Genetics | Activity: Research and Development | Company Description Datar Cancer Genetics develops blood-based diagnostics for early cancer detection and identifies personalized treatment strategies based on genomic and cellular analysis of a patient's cancer. | Location Morrisville | |
Company Dechra Pharmaceuticals | Activity: Research and Development | Company Description Dechra Pharmaceuticals develops veterinary pharmaceuticals with a focus on major companion animal categories. | Location Greensboro | |
Company Deep Blue Medical Advances Inc. | Activity: Research and Development | Company Description Deep Blue Medical Advances develops a surgical mesh for hernia repair and other medical device technologies from Duke University. | Location Durham | |
Company Deep Creek Pharma LLC | Activity: Research and Development | Company Description DeepCreek Pharma is commercializing CF10 fluoropyrimidine polymer technology to treat colon cancer. | Location Yadkinville | |
Company DelAQUA Pharmaceuticals Inc. | Activity: Research and Development | Company Description DelAQUA Pharmaceuticals is developing technology to enhance the solubility and stability of drugs and drug candidates and to improve their efficacy and safety. | Location Chapel Hill | |
Company Denizen Biologics LLC | Activity: Research and Development | Company Description Denizen Biologics develops gene therapy vectors to enhance the capability of genetic medicine and improve the outcomes for patients. | Location Cary |